The genetic disease harlequin ichthyosis affects the transport of fats within the skin, resulting in hard, scalelike plaques ...

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...

Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

New research suggests the lack of a bacterium known to help infants digest breast milk could have significant consequences ...

The U.S. Food and Drug Administration (FDA) has announced a three-month extension for its review of the supplemental New Drug ...

Success of surgical treatment is more commonly determined by crude metrics including readmission to hospital, length of stay and operative time.21 22 Condition-specific outcomes such as faecal ...

ABSTRACT. INTRODUCTION: Tegaserod, a selective 5-HT4 agonist, is a promotility agent used for the treatment of adults with irritable bowel syndrome with constipation and chronic idiopathic ...

Learn the causes and potential treatments for mucus in a baby's stool, including when it's normal and when to talk with a doctor.

Treatment will depend on your child’s symptoms, age, and general health. It will also depend on how bad the condition is. Some children may not need treatment. A child with TD can usually function ...

In “The Protocol,” we explore the controversial debate over health care for trans youth.

A new six-part podcast explores the story of medical treatment for transgender young people — how the care began, the lives it changed, and the legal and political fights that could end it in ...